| Craig R Hoekzema, MD | |
|
1450 Farr Rd, 5000, Norton Shores, MI 49444-9770 | |
| (231) 739-9095 | |
| (231) 722-5147 |
| Full Name | Craig R Hoekzema |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 13 Years |
| Location | 1450 Farr Rd, Norton Shores, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144519299 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 4301108926 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health Hackley Campus | Muskegon, MI | Hospital |
| Spectrum Health Ludington Hospital | Ludington, MI | Hospital |
| Mercy Health Lakeshore Campus | Shelby, MI | Hospital |
| Metro Health Hospital | Wyoming, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Shore Otolaryngology Pc | 4284998154 | 7 |
News Archive
Until now there were only indirect evidence of the transfer of thyroid hormones from mother to fetus through the placenta during pregnancy. That event is very important because the maternal thyroid hormones appear to play a key role in the development of the nervous system and other organs of the fetus; so it's true that in case of maternal thyroid disease, such hypothyroidism, have a direct bearing on the unborn child with reduction, also significant, to its Q.I..
NexMed, Inc., a developer of products based on the NexACT® technology, today announced the closing of its acquisition of Bio-Quant, Inc., a privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA. Upon closing, Bio-Quant became a wholly-owned subsidiary of NexMed.
Scientists have created a viable technology to improve the detection of leukemia cells in bone marrow.
Led by researchers at Lawson Health Research Institute, a multi-centre registry trial is testing the use of a new imaging tracer, called a PSMA tracer, for early detection of recurrent prostate cancer. The registry gives patients access to a new type of imaging and will assess the impact on patient care.
› Verified 7 days ago
| Entity Name | West Shore Otolaryngology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548764426 PECOS PAC ID: 4284998154 Enrollment ID: O20180430001754 |
News Archive
Until now there were only indirect evidence of the transfer of thyroid hormones from mother to fetus through the placenta during pregnancy. That event is very important because the maternal thyroid hormones appear to play a key role in the development of the nervous system and other organs of the fetus; so it's true that in case of maternal thyroid disease, such hypothyroidism, have a direct bearing on the unborn child with reduction, also significant, to its Q.I..
NexMed, Inc., a developer of products based on the NexACT® technology, today announced the closing of its acquisition of Bio-Quant, Inc., a privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA. Upon closing, Bio-Quant became a wholly-owned subsidiary of NexMed.
Scientists have created a viable technology to improve the detection of leukemia cells in bone marrow.
Led by researchers at Lawson Health Research Institute, a multi-centre registry trial is testing the use of a new imaging tracer, called a PSMA tracer, for early detection of recurrent prostate cancer. The registry gives patients access to a new type of imaging and will assess the impact on patient care.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Craig R Hoekzema, MD 1450 Farr Rd, 5000, Norton Shores, MI 49444-9770 Ph: (231) 739-9095 | Craig R Hoekzema, MD 1450 Farr Rd, 5000, Norton Shores, MI 49444-9770 Ph: (231) 739-9095 |
News Archive
Until now there were only indirect evidence of the transfer of thyroid hormones from mother to fetus through the placenta during pregnancy. That event is very important because the maternal thyroid hormones appear to play a key role in the development of the nervous system and other organs of the fetus; so it's true that in case of maternal thyroid disease, such hypothyroidism, have a direct bearing on the unborn child with reduction, also significant, to its Q.I..
NexMed, Inc., a developer of products based on the NexACT® technology, today announced the closing of its acquisition of Bio-Quant, Inc., a privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA. Upon closing, Bio-Quant became a wholly-owned subsidiary of NexMed.
Scientists have created a viable technology to improve the detection of leukemia cells in bone marrow.
Led by researchers at Lawson Health Research Institute, a multi-centre registry trial is testing the use of a new imaging tracer, called a PSMA tracer, for early detection of recurrent prostate cancer. The registry gives patients access to a new type of imaging and will assess the impact on patient care.
› Verified 7 days ago
Dr. Matthew Allen Bowen, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1450 Farr Rd, Norton Shores, MI 49444 Phone: 231-739-9095 Fax: 231-739-6439 | |
Dr. Paul Henri Belanger, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1450 Farr Rd Ste 5000, Norton Shores, MI 49444 Phone: 231-777-2625 Fax: 231-773-8560 | |
Arthur James Potter Jr., MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1450 Farr Rd, Suite 5000, Norton Shores, MI 49444 Phone: 231-739-9095 Fax: 231-722-5147 | |
Dr. Paul E Lomeo, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1450 Farr Rd Ste 5000, Norton Shores, MI 49444 Phone: 231-777-2625 Fax: 231-773-8560 |